Profiel
Scott Lauder worked as VP-Process Sciences & Clinical Manufacturing at Merrimack Pharmaceuticals, Inc. from 2013 to 2016.
He then worked as Chief Technology Officer at Gemini Therapeutics, Inc. from 2016 to 2021.
Lauder holds a doctorate degree from Northwestern University and an undergraduate degree from the University of Manitoba.
Eerdere bekende functies van Scott Lauder
| Bedrijven | Functie | Einde |
|---|---|---|
| GEMI THER | Hoofd Techniek/Wetenschap/O&O | 17-09-2021 |
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-10-2016 |
Opleiding van Scott Lauder
| University of Manitoba | Undergraduate Degree |
| Northwestern University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |